Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Stimulant Drugs

  • Chapter
The Pharmacology of Sleep

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 116))

Abstract

Plants containing central stimulants were identified by man several thousand years ago. Most of these plants were used as ancient drugs, examples of which are tea leaves in China and India, coffee beans and cola nuts in South America, ma huang in China, khat leaves in Africa, and coca leaves in South America. The early histories of the central stimulant drugs are described in detail by Angrist and Sudilovsky (1978).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 429.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 549.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abe K (1977) Lithium prophylaxis of periodic hypersomnia. Br J Psychiatry 130: 312–316

    Article  PubMed  CAS  Google Scholar 

  • Akimoto H, Honda Y, Takahashi Y (1960) Pharmacotherapy in narcolepsy. Dis Nerv Syst 21:1–3

    Google Scholar 

  • Aldrich MS (1990) Narcolepsy. N Engl J Med 323:389–394

    Article  CAS  Google Scholar 

  • Aldrich MS, Roger AE (1989) Exacerbation of human cataplexy by prazosin. Sleep 12:254–256

    PubMed  CAS  Google Scholar 

  • Angrist B, Sudilovsky A (1978) Central nervous system stimulants: historical aspects and clinical effects. In: Iversen LL, Iversen SD, Snyder SH (ed) Stimulants. Plenum, New York, pp 99–165 (Handbook of psychopharmacology, vol 11)

    Google Scholar 

  • Angrist B, Rotorosen J, Kleinberg D, Merriam V, Gershon S (1977) Dopaminergic agonist properties of ephedrine: theoretical implications. Psychopharmacology (Berl) 55:115–120

    Article  CAS  Google Scholar 

  • Arrigoni J, Nishino S, Shelton J, Elizaga R, Mignot E (1993) CG3703, an analog of TRH, decreases cataplexy in canine narcolepsy. Sleep Res 22:488

    Google Scholar 

  • Bastuji H, Jouvet M (1988) Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 12: 695–700

    Article  PubMed  CAS  Google Scholar 

  • Benoit O, Clodore M, Touron N, Paihous E (1987) Effects of modafinil on sleepiness in normal sleep deprived and symptomatic subjects. 5th International Congress of Sleep Research, June 28–July 3, Copenhagen

    Google Scholar 

  • Biel JH, Bopp BA (1978) Amphetamines: structure-activity relationships. In: Iversen LL, Iversen SD, Snyder SH (eds) Stimulants. Plenum, New York, pp 1–39 (Handbook of psychopharmacology, vol 11)

    Google Scholar 

  • Billiard M, Guilleminault C, Dement WC (1975) A menstruation-linked periodic hypersomnia. Neurology (Minneap) 25:436–443

    Article  CAS  Google Scholar 

  • Billiard M, Dissoubray C, Lubin S, Touchon J, Besset A (1988) Effects of modafinil in patients with narcolepsy-cataplexy or with idiopathic hypersomnia. 9th European Congress of Sleep Research, Sept 4–9, Jerusalem

    Google Scholar 

  • Billiard M, Laffont F, Goldenberg F, Weil J-S, Lubin S (1991) Placebo-controlled, cross-over study of modafinil therapeutic effect in narcolepsy. Sleep Res 20A: 289

    Google Scholar 

  • Broughton R, Mamelak M (1980) Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy. Can J Neurol Sci 7:23–31

    PubMed  CAS  Google Scholar 

  • Broughton R, Ghanem Q, Hishikawa Y, Sugita Y, Nevsimalova S, Roth B (1983) Life effects of narcolepsy: relationships to geographic origin (North American, Asian or European) and to other patient and illness variables. Can J Neurol Sci 10:100–104

    PubMed  CAS  Google Scholar 

  • Chen KK, Schmidt CF (1925) The action of ephedrine, the active principle of the Chinese drug Ma Huang. J Pharmacol Exp Ther 24:339–357

    Google Scholar 

  • Connel PH (1972) Central nervous system stimulants. In: Herxheimer ML (ed) Side effects of drugs, vol 7. Excerpta Medica, Amsterdam, pp 1–16

    Google Scholar 

  • Daly DD, Yoss RE (1956) The treatment of narcolepsy with methyl-phenylpiperidylacetate: a preliminary report. Proc Mayo Clin 31:620–625

    CAS  Google Scholar 

  • Daly DD, Yoss RT (1974) Narcolepsy. In: Vinken PJ, Bruyn GW (eds) The epilepsies. North-Holland, Amsterdam, pp 836–852 (Handbook of clinical neurology, vol 15)

    Google Scholar 

  • Daniels LE (1930) A symptomatic treatment of narcolepsy. Proc Mayo Clin 5: 299–300

    Google Scholar 

  • Diagnostic Classification Steering Committee (1990) International classification of sleep disorders: diagnostic and coding manual. American Sleep Disorders Association, Rochester

    Google Scholar 

  • Eaton LM (1943) Treatment of narcolepsy with desoxy-ephedrine hydrochloride. Proc Mayo Clin 18:262–264

    Google Scholar 

  • Elwes RDC, Crewes H, Chesterman LP, Summers B, Jenner P, Binnie CD (1989) Treatment of narcolepsy with L-tyrosine: double-blind placebo-controlled trial. Lancet 2:1067–1069

    Article  PubMed  CAS  Google Scholar 

  • Engstrom RG, Kelly LA, Gogerty JH (1975) The effects of 5-hydroxy-5-(4,1-chlorophenyl)-2,3-dihydro-5H-imidazo[2,1-a] isonidole (mazindol, SaH 42–548) on the metabolism of brain norepinephrine. Arch Int Pharmacodyn Ther 214: 308–321

    PubMed  CAS  Google Scholar 

  • Gittelman R (1983) Experimental and clinical studies of stimulant use in hyperactive children and children with other behavioral disorders. In: Creese I (ed) Stimulants: neurochemical, behavioral, and clinical perspectives. Raven, New York, pp 205–226

    Google Scholar 

  • Guilleminault C (1989) Narcolepsy syndrome. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine. Saunders, Philadelphia, pp 338–346

    Google Scholar 

  • Guilleminault C (1993) Amphetamines and narcolepsy. Sleep 16:199–201

    PubMed  CAS  Google Scholar 

  • Guilleminault C, Carskadon M, Dement WC (1974) On the treatment of rapid eye movement narcolepsy. Arch Neurol 30:90–93

    Article  PubMed  CAS  Google Scholar 

  • Guilleminault C, Mancuso J, Salva MA, Hayes B, Mitler M, Poirier G, Montplaisir J (1986) Viloxazine hydrochloride in narcolepsy: a preliminary report. Sleep 9:275–279

    PubMed  CAS  Google Scholar 

  • Hadler AJ (1972) Mazindol, a new non-amphetamine anorexigenic agent. J Clin Pharmacol 12:453–458

    CAS  Google Scholar 

  • Hart EJ (1985) Kleine-Levine syndrome: normal CSF monoamines and response to lithium therapy. Neurology 35:1395–1396

    Article  PubMed  CAS  Google Scholar 

  • Hishikawa Y (1987) Sleep and wakefulness disorders (in Japanese). In: Kakeda K, Shimazono Y, Okuma T, Takahashi R, Hosaki H (eds) Handbook of psychiatry, vol 87-B. Nakayama, Tokyo, pp 189–236

    Google Scholar 

  • Hishikawa Y (1990) Narcolepsy (in Japanese). Clin Neurosci 8:1266–1268

    Google Scholar 

  • Hishikawa Y, Nakai K, Ida H, Kaneko Z (1965) The effect of imipramine, desmethylimipramine and chlorpromazine on the sleep-wakefulness cycle of the cat. Electroencephalogr Clin Neurophysiol 19:518–521

    Article  PubMed  CAS  Google Scholar 

  • Hishikawa Y, Ida H, Nakai K, Kaneko Z (1966) Treatment of narcolepsy with imipramine (Tofranil) and desmethylimipramine (Pertofran). J Neurol Sci 3:453–461

    Article  PubMed  CAS  Google Scholar 

  • Hishikawa Y, Nan’no H, Tachibana M, Furuya E, Koida H, Kaneko Z (1968) The nature of sleep attack and other symptoms of narcolepsy. Electroencephalogr Clin Neurophysiol 24:1–10

    Article  PubMed  CAS  Google Scholar 

  • Hishikawa Y, Sugita Y, Iijima S (1978) Therapeutic effects of methylphenidate in narcoleptic patients (in Japanese). Basic Pharmacol Ther 6:2166–2178

    Google Scholar 

  • Honda Y, Hishikawa Y (1980) A long-term treatment of narcolepsy and excessive daytime sleepiness with pemoline (Betanamine). Curr Ther Res 27:429–441

    Google Scholar 

  • Honda Y, Hishikawa Y, Takahashi Y (1979) Long-term treatment of narcolepsy with methylphenidate (Ritalin). Curr Ther Res 25:288–298

    Google Scholar 

  • Honda Y, Asaka A, Tanaka Y, Juji T (1983a) Discrimination of narcoleptic patients by using genetic markers and HLA. Sleep Res 12:254

    Google Scholar 

  • Honda Y, Asaka A, Tanimura M, Furusho T (1983b) A genetic study of narcolepsy and excessive daytime sleepiness in 308 families with a narcolepsy of hypersomnia proband. In: Guilleminault C, Lugaresi E (eds) Sleep/wake disorders: natural history, epidemiology and long term evolution. Raven, New York, pp 187–199

    Google Scholar 

  • Iijima S, Sugita Y, Teshima Y, Hishikawa Y (1986) Therapeutic effects of mazindol on narcolepsy. Sleep 9:265–268

    PubMed  CAS  Google Scholar 

  • Janota O (1931) Symptomatische Behandlung der pathologischen Schlafsucht, besonders der Narkolepsie. Med Klin 27:278–281

    Google Scholar 

  • Kales A, Cadieux RJ, Soldatos CR, Bixler EO, Schweitzer PK, Prey WT, Vela-Bueno A (1982a) Narcolepsy-cataplexy. I. Clinical and electrophysiologic characteristics. Arch Neurol 39:164–168

    Article  Google Scholar 

  • Kales A, Soldatos CR, Bixler EO, Caldwell A, Cadieux RJ, Verrichio JM, Kales JD (1982b) Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology. Arch Neurol 39:169–171

    Article  Google Scholar 

  • Kales A, Vela-Bueno A, Kales JD (1987) Sleep disorders: sleep apnea and narcolepsy. Ann Intern Med 106:434–443

    PubMed  CAS  Google Scholar 

  • Kalix P (1992) Cathionine, a natural amphetamine. Pharmacol Toxicol 70:77–86

    Article  PubMed  CAS  Google Scholar 

  • Kayukawa Y, Yoshiga S, Okada T (1980) Therapeutic effects of lithium carbonate on periodic hypersomnia (in Japanese). Psychiatr Neurol Jpn 82:313–314

    Google Scholar 

  • Kessler S, Guilleminault C, Dement WC (1974) A family of 50 REM narcolepsy. Arch Neurol Scand 50:503–512

    Article  CAS  Google Scholar 

  • Klein RG (1987) Pharmacotherapy of childhood hyperactivity: an update. In: Meltzer H Y (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp 1215–1224

    Google Scholar 

  • Kuczenski R (1983) Biochemical actions of amphetamine and other stimulants. In: Creese I (ed) Stimulants: neurochemical, behavioral, and clinical perspectives. Raven, New York, pp 31–61

    Google Scholar 

  • Lammers GJ, Arends J, Declerck AC, Ferrari MD, Schouwink G, Troost J (1993) Gamma-hydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep 16:216–220

    PubMed  CAS  Google Scholar 

  • Langdon N, Bandak S, Shindler J, Parkes JD (1986) Fluoxetine in the treatment of cataplexy. Sleep 9:371–372

    PubMed  CAS  Google Scholar 

  • Laurent JM (1962) Toxique et toxicomanie peu connus, “le cath”. Ann Med Psychol (Paris) 120:649–657

    Google Scholar 

  • Lyons TJ, French J (1991) Modafinil: the unique properties of a new stimulant. Aviat Space Environ Med May: 432–435

    Google Scholar 

  • Mamelak M (1989) Gamma-hydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci Biobehav Rev 13:187–198

    Article  PubMed  CAS  Google Scholar 

  • Mamelak M, Scharf MB, Woods M (1986) Treatment of narcolepsy with gamma-hydroxybutyrate: a review of clinical and sleep laboratory findings. Sleep 9: 285–289

    PubMed  CAS  Google Scholar 

  • Marangos PJ, Paul SM, Parma AM, Goodwin FK, Syapin P, Skolnick P (1979) Purinergic inhibition of diazepam binding to rat brain. Life Sci 24:851–857

    Article  PubMed  CAS  Google Scholar 

  • Martin WR, Sloan JW, Sapria JD, Jasinski DR (1971) Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 12:245–258

    PubMed  CAS  Google Scholar 

  • Meier R, Gross F, Tripod J (1954) Ritaline, eine neuartige synthetische Verbindung mit spezifischer zentralerregender Wirkungskomponente. Klin Wochenschr 32:445–450

    Article  PubMed  CAS  Google Scholar 

  • Mitler MM, Erman M, Hajdukovic R (1993) Amphetamine and narcolepsy: the treatment of excessive somnolence with stimulant drugs. Sleep 16:203–206

    PubMed  CAS  Google Scholar 

  • Montplaisir J, Gobout R (1983) A new treatment for cataplexy. 4th International Congress of Sleep Research, Bologna

    Google Scholar 

  • Mouret J, Lemoine P, Sanchez P, Robelin N, Taillard J, Canini F (1988) Treatment of narcolepsy with L-tyrosine. Lancet 2:1458–1459

    Article  PubMed  CAS  Google Scholar 

  • Nishino S, Shelton J, Renaud A, Dement WC, Mignot E (1993) The role of 5HT-1A receptor mechanisms in canine narcolepsy. Sleep Res 22:42

    Google Scholar 

  • Ogura C, Okuma T, Nakazawa K, Kishimoto A (1976) Treatment of periodic somnolence with lithium carbonate. Arch Neurol 33:143

    Article  PubMed  CAS  Google Scholar 

  • Papy JJ, Conte-Devoix B, Sormani J, Porto R, Guillaume V (1982) Syndrome d’hypersomnie périodique avec mégaphagie chez une jeune femme, rhythmé par le cycle menstruel. Rev Electroencephalogr Clin Neurophysiol 12:54–61

    Article  CAS  Google Scholar 

  • Parkes JD, Dahlitz M (1993) Amphetamines and narcolepsy: amphetamine prescription. Sleep 16:201–203

    PubMed  CAS  Google Scholar 

  • Parkes JD, Schachter M (1979) Mazindol in the treatment of narcolepsy. Acta Neurol Scand 60:250–254

    Article  PubMed  CAS  Google Scholar 

  • Parkes JD, Baraitser M, Marsden CD, Asselman P (1975) Natural history, symptoms and treatment of the narcoleptic syndrome. Acta Neurol Scand 52:337–353

    Article  PubMed  CAS  Google Scholar 

  • Pelhan WE Jr, Sturges J, Hoza J, Schmidt C, Bijlsma JJ, Milich R, Moore S (1987) Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder. Pediatrics 80:491–501

    Google Scholar 

  • Phillis JW, Edstrom JP, Kostopoulos GK, Kirkpatrick JR (1979) Effects of adenosine and adenine nucleotides on synaptic transmission in the cerebral cortex. Can J Physiol Pharmacol 57:1289–1312

    Article  PubMed  CAS  Google Scholar 

  • Prinzmetal M, Alles GA (1940) The central nervous system stimulant effects of dextro-amphetamine sulphate. Am J Med Sci 200:665–673

    CAS  Google Scholar 

  • Prinzmetal M, Bloomberg W (1935) Use of benzedrine for treatment of narcolepsy. JAMA 105:2051–2054

    Article  CAS  Google Scholar 

  • Roselaar SE, Langdon N, Lock CB, Jenner P, Parkes JD (1987) Selegiline in narcolepsy. Sleep 10:491–495

    PubMed  CAS  Google Scholar 

  • Sachs C, Persson HE, Hagenfeldt K (1982) Menstruation-related periodic hypersomnia: a case study with successful treatment. Neurology 32:1376–1379

    Article  PubMed  CAS  Google Scholar 

  • Scharf M, Brown D, Woods M, Brown L, Hirschowitz J (1985) The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatry 46:222–225

    PubMed  CAS  Google Scholar 

  • Schnackenberg RC (1973) Caffeine as a substitute for schedule II stimulants in hyperactive children. Am J Psychiatry 130:796–800

    PubMed  CAS  Google Scholar 

  • Schrader H, Kayed K, Bendixen Markset A-C, Treiden HE (1986) The treatment of accessory symptoms in narcolepsy: a double-blind cross-over study of a selective serotonin re-uptake inhibitor (femoxetine) versus placebo. Acta Neurol Scand 74:297–303

    Article  PubMed  CAS  Google Scholar 

  • Scrima L, Hartman PG, Johnson FH Jr, Hiller FC (1989) Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures. Biol Psychiatry 26:331–343

    Article  PubMed  CAS  Google Scholar 

  • Shimizu N, Take S, Hori T, Oomura Y (1991) Hypothalamic microdialysis of mazindol causes anorexia with increase in synaptic serotonin in rats. Physiol Behav 49:131–134

    Article  PubMed  CAS  Google Scholar 

  • Sirtori C, Hurwitz A, Azarnof DL (1971) Hyperinsulinemia seconday to chronic administration of mazindol and d-amphetamine. Am J Med Sci 261:341–349

    Article  PubMed  CAS  Google Scholar 

  • Takahashi Y (1965) Clinical studies of periodic somnolence: analysis of 28 personal cases. Psychiatr Neurol Jpn 67:853–889

    CAS  Google Scholar 

  • Takahashi Y, Honda Y (1964) Pharmacotherapy in narcolepsy. I. Effects of central nervous system stimulant (in Japanese). Clin Psychiatry 6:673–682

    Google Scholar 

  • Thorpy MJ (1990) Handbook of sleep disorders. Dekker, New York

    Google Scholar 

  • Wyatt R, Fram D, Buchbinder R, Snyder F (1971) Treatment of intractable narcolepsy with a monoamine oxidase inhibitor. N Engl J Med 285:987–991

    Article  PubMed  CAS  Google Scholar 

  • Yoss RE, Daly DD (1959) Treatment of narcolepsy with Ritalin. Neurology (Minneap) 9:171–173

    Article  CAS  Google Scholar 

Download references

Authors
  1. Y. Hishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sleep Research and Treatment Center, Pennsylvania State University College of Medicine M.S. Hershey Medical Center, 500 University Drive, Hershey, PA, 17033, USA

    Anthony Kales M.D. (Professor and Chairman Department of Psychiatry and Director) (Professor and Chairman Department of Psychiatry and Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hishikawa, Y. (1995). Stimulant Drugs. In: Kales, A. (eds) The Pharmacology of Sleep. Handbook of Experimental Pharmacology, vol 116. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57836-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57836-6_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63372-0

  • Online ISBN: 978-3-642-57836-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation